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Background: Spinal bone metastases are commonly diagnosed in cancer patients. The consequences are pain
both at rest and under exercise, impairment of activities of daily life (ADL), reduced clinical performance, the risk
of pathological fractures, and neurological deficits. The aim of this randomized, controlled pilot trial was to
investigate the feasibility of muscle-training exercises in patients with spinal bone metastases under
radiotherapy. Secondary endpoints were local control, pain response and survival.
Methods: This study was a prospective, randomized, monocentre, controlled explorative intervention trial to
determine the multidimensional effects of exercises for strengthening the paravertebral muscles. On the days of
radiation treatment, patients in the control group were physically treated in form of respiratory therapy. Sixty
patients were randomized between September 2011 and March 2013 into one of the two groups: differentiated
resistance training or physical measure with thirty patients in each group.
Results: The resistance training of the paravertebral muscles was feasible in 83.3% of patients (n = 25). Five
patients died during the first three months. The exercise group experienced no measurable side effects. “Chair
stand test” in the intervention group was significant enhanced with additionally improved analgesic efficiency.
Patients in intervention group improved in pain score (VAS, 0–10) over the course (p < .001), and was significant
better between groups (p = .003) after 3 months. The overall pain response showed no significant difference
between groups (p = .158) There was no significant difference in overall and bone survival (survival from first
diagnosed bone metastases to death).
Conclusions: Our trial demonstrated safety and feasibility of an isometric resistance training in patients with
spinal bone metastases. The results offer a rationale for future large controlled investigations to confirm these
findings.
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The vertebral column is the main localization of bone me-
tastases, where they frequently indicate an advanced stage
of a malignant primary disease [1,2]. Two thirds of all
tumor patients are estimated to develop bone metastases
in the course of their disease [3]. The clinical symptoms
include pain at rest and under exercise, but also impaired
activity of daily life (ADL), the risk of pathological frac-
tures, and neurological deficits. Standard clinical care
often includes patient immobilization either by means of
an orthopedic thoracic corset or by confining the patient
to bed in order to prevent pathological fractures. Regard-
ing pain therapy and recalcification of former osteolytic le-
sions, palliative radiotherapy (RT) represents an effective
treatment option [4].
As the central axial organ of the human body, the verte-
bral column is involved in all physical movements and any
spinal impairment with critically limited patient mobility.
The paravertebral muscles greatly contribute to relief of
pressure on the spine and, therefore, have a share in the
realization of mobility. For this reason, exercise-related in-
terventions have until now been excluded in patients with
bone metastases, and the literature does not describe any
targeted training-therapeutic measures involving isometric
muscle exercise in these patients. There are, however, nu-
merous findings that indicate the positive effect of targeted
physical training measures in tumor patients regarding
practicability, pain, and mobility [5-10]. Correspondingly,
the effect of resistance training as an adjunct to RT in pa-
tients with bone metastases is still unknown. In these pa-
tients with a generally advanced stage of the tumor, a
painful vertebral column, and in a reduced general phys-
ical condition, this prospective trial presents a challenge in
the investigation of the feasibility of a targeted, routine,
and differentiated training program for strengthening the
paravertebral muscles in patients with bone metastases of
the vertebral column. An aspect of critical importance is
first to distinguish between stable and unstable lesions,
since an acute instability represents a contraindication for
resistance training in patients with bone metastases. The
aim of our trial was to analyze the feasibility of a combin-
ation therapy, in patients with spinal metastases in order
to promote early mobility.
Methods
Subjects, recruitment strategy, and eligibility
for enrolment
From September 2011 to March 2013, 80 patients with a
histologically confirmed tumor diagnosis and also solitary
or multiple bone metastases of the thoracic or lumbar seg-
ments of the vertebral column or of the sacral region were
screened in our department. Initially all patients were di-
agnosed with painful bone metastases requiring RT. Inclu-
sion criteria were an age of 18 to 80 years, a Karnofskyperformance score [11] ≥ 70, written declaration of in-
formed consent, and already initiated bisphosphonate
therapy. Furthermore, only patients with stable vertebral-
body lesions were included. This was diagnosed independ-
ently by a specialist for radiology as well as by a specialist
for orthopedic surgery. Only a metastasis classified by
both specialists as “stable” was suggested eligible for inclu-
sion. Patients with significant neurological or psychiatric
disorders – including dementia and epilepsy, contractual
incapacity, and diagnosed vertebral-body instability or in-
volvement of the cervical spine were excluded. Fifteen pa-
tients were excluded due to unstable metastases, and five
patients declined to participate in the study. Sixty patients
fulfilled the inclusion and exclusion criteria and were en-
rolled into the trial (Figure 1). The study was approved by
the Heidelberg Ethics Committee (Nr. S-316/2011).
Design, randomized allocation, and procedures
This was a randomized, monocentre, controlled, explorative
intervention study with the intention to determine the feasi-
bility of a resistance training program for strengthening the
paravertebral muscles in patients with spinal bone metasta-
ses under RT. The intervention was conducted initially
under guidance and was subsequently continued by the in-
dividuals themselves. The control group underwent physical
therapy in the form of respiration exercises and “hot roll”
treatments. The patients were subjected to a staging of their
vertebral column within the context of the computer tom-
ography scans (CT) designed to plan the RT schedule prior
to enrolment into the trial. In this examination the osteolytic
metastases in the thoracic and lumbar spine were classified
according to Taneichi [12] and correspondingly classified as
“stable” or “unstable”. The subtypes A-C were defined as
“stable” in thoracic and lumbar spine (Figure 2). Osteo-
blastic and mixed metastases were assessed separately, since
the Taneichi score can only be used for the assessment of
osteolytic metastases. After completion of the measurement
of the baseline findings, patients with stable bone metastases
were allocated to one of the two treatment groups by
randomization. A block randomization approach with block
size 6 was used to ensure that the two intervention groups
were balanced equally. A random list was used SAS 9.1.
After the baseline measurements, the patients were assigned
to the respective treatment arms on a 1:1 basis according to
the randomization list. The randomization procedure was
carried out by a central office. The data of the patient re-
cords were collected by the authors. The evaluation in-
cluded all recorded data up to the time of the three-month
follow-up interval. The data of the patient characteristics are
presented in summary Table 1.
Study interventions
Arm A (intervention group, differentiated resistance train-
ing) and in Arm B (control group, physical “respiratory”
80 patients screened
15 unstable metastases
5 patients rejected trial
60 patients enrolled with 
stable metastases
30 randomly assigned to 
intervention group 
30 randomly assigned to 
control group 
30 completed assisted 
intervention
25 completed 12 week 
follow-up in intervention 
group
30 completed control 
group
23 completed 12 week 
follow-up in control group
Figure 1 Flow of participants through the trial.
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started on the same day with RT and were performed on
each of the treatment days (Monday until Friday) over a
two-week period, independent of the number of RT frac-
tions. The sports intervention lasted approximately 30 min,
the “respiratory” measure approximately 15 min [13]. The
patients exhibit differences in terms of age, physical consti-
tution, gender, stage of tumor, general state of health, bone
density, and pain symptoms, which is why the muscle-
exercise concept was kept as simple as possible. Since the
site of the bone metastases differed from patient to patient,
three different exercises were enacted to ensure an even
isometric training of the muscles along the entire vertebral
column. The participants of the control group were given
physical therapy in the form of respiration exercises and
“hot roll” treatments also for a period of two weeks. A de-
tailed report of the sports intervention and its application
has already been published [14].
After completion of RT schedule or, respectively, after
two weeks, patients in the training group were guided to
continue exercises, which were demonstrated to them by
their therapist in the one-on-one situation, on their own at
home for a further twelve weeks. The training exercises
were documented. The patients in the control group did
not carry out any further measures at home after the two-
week therapy period. The target parameters were measuredat the start of RT (t0), at the end (t1), and after twelve weeks
(t2). The target parameters comprise the documentation of
the training program, the pain score according to the visual
analog scale (VAS), the completion of the activity ques-
tionnaire, and the recording of patient-specific data. Since
it was not possible to quantitatively measure the power of
the paravertebral muscles as a baseline value and to moni-
tor the success of the training, the so-called “chair stand”
test [15] was carried out at all measurement intervals. In
this test the subjects were asked to stand up from the sit-
ting position as many times as possible within a period of
30 seconds, with the number of times being recorded as
the score.
Assessment of the primary and secondary endpoints
The aim of the trial was to evaluate the feasibility of the
defined training program. The feasibility as the primary
endpoint was defined as the completion of the training pro-
gram up to three months after the end of RT (t2). In
addition, the evaluation of the mobility aspect included the
performance of the chair-stand test at the individual investi-
gation intervals. The item taken as the secondary endpoint
was the activity of the patients as documented on an activ-
ity questionnaire specially designed for this trial and com-
pleted on the individual days of examination (Table 2). We
created questions independently which were relevant for
Thoracic spine Lumbar spine
A B A B
C D C D
E F E F
G
A B C D E F
Tumor occupancy vertebral body 30% 60% 30% 60% 30% 60%
Costovertebral Joint Destruction + + + +
Predicle Destruction + +
Posterior Elements Destruction +
Predicted Probability of Collapse 0.13 0.68 0.57 0.96 0.71 0.98
A B C D E F G
Tumor occupancy vertebral body 20% 30% 40% 40% 60% 5% 20%
Predicle Destruction + + + +
Posterior Elements Destruction + + +
Predicted Probability of Collapse 0.07 0.25 0.60 0.99 0.99 0.06 0.38
Figure 2 Taneichi score [20].
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Table 1 Patient characteristics at baseline
Intervention




n % n %
Age (years)
Mean (SD) 61.3 (10.1) 64.1 (10.9) 0.304
Gender
Male 14 46.7 19 63.3 0.195
Female 16 53.3 11 36.7
Weight (kg, SD) 74.3 (14.7) 72.7 (12.1) 0.553
Height (cm, SD) 171.2 (8.3) 172.3 (7.5) 0.906
Body mass index
Mean (SD) 25.3 (4.5) 24.4 (3.6) 0.559
Karnofsky-index
(median, range)
80 (70–100) 80 (70–100) 1.000
Primary site
Lung cancer 12 9.2 8 26.6 0.320
Breast cancer 5 16.7 6 20.1 0.542
Prostate cancer 5 16.7 9 30.1 0.156
Melanoma 1 3.3 1 3.3 1.000
Renal cancer 1 3.3 2 6.7 0.875
Other 6 20.1 4 13.4 0.325
Localization metastases 0.717
Thoracic 17 56.7 14 46.7
Lumbar 9 30.0 13 43.3
Thoracic and lumbar 2 6.7 2 6.7
Sacrum 2 6.7 1 3.3
Number metastases 0.257
Mean (range) 1.4 (2–4) 1.7 (1–5)
Solitary 22 73.3 18 60.0
Multiple 8 26.7 12 40.0
Type of metastases 0.961
Mixed 2 6.7 2 6.7 1.000
Osteoblast 9 30.0 10 33.3 0.956
Osteolytic 19 63.3 18 60.0 .0932
Distant metastases
at baseline
Visceral 12 40.0 5 16.7 0.045
Brain 3 10.0 3 10.0 1.000
Lung 7 23.3 4 13.3 0.320
Tissue 8 26.7 6 20.0 0.542
Hormonotherapy 10 33.3 16 53.3 0.118
Immunotherapy 7 23.3 5 16.7 0.519
Chemotherapy 25 83.3 20 66.7 0.136
Pathological fracture
at baseline
6 20.0 9 30.0 0.379
Neurological deficit 0 0.0 2 6.7 0.150
Table 1 Patient characteristics at baseline (Continued)
Orthopedic corset
at baseline






3 (2–4) 3 (2–4) 1.000
Cumulative dose
(median, range)
30 (30–40) 30 (30–40) 1.000
Abbreviations: SD Standard deviation.
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assessed by means of CT images taken prior to and three
months after RT. The pain response was documented on
the VAS (range 0–10). Complete response (CR) was defined
as VAS= 0 after three months, partial response (PR) as an
improvement by at least two score points after three
months, according to the international consensus response
categories by Chow et al. [16]. Overall survival (OS) was de-
fined as time from initial diagnosis until death, bone sur-
vival as time from initial diagnosis of spinal bone metastasis
until death.Compliance with the intervention
During the two-week period of RT, patients in the training
group (Arm A) performed exercises under the guidance of
a physiotherapist. The patients were then requested to carry
out the defined training program in their home setting
three times a week and to document the exercises them-
selves. We could improve the compliance with no imple-
ments for home training, and the exercises were practicable
easily. This training schedule was verified at the t2 follow-
up interval.Radiotherapy
Radiotherapy was performed in our department. After
virtual simulation was performed to plan the radiation
schedule, radiotherapy was carried out over a dorsal
photon field of the 6MV energy range. Primary target
volume (PTV) covered the specific vertebral body af-
fected as well as the ones immediately above and below.
In Arm A, 24 patients (80%) were treated with 10 ×
3 Gy, three patients (10%) with 14 × 2.5 Gy, and three
patients (10%) with 20 × 2 Gy. In Arm B, the RT proto-
cols for 28 patients (93.4%) were 10 × 3 Gy, for one pa-
tient (3.3%) 14 × 2.5 Gy, and for one patient (3.3%) 20 ×
2 Gy. The median single dose was 3 Gy (range 2–3 Gy),
the median total dose 30 Gy (range 20–35 Gy). The sin-
gle and total doses were decided separately for each pa-
tient, depending on the histology, the patient’s general
state of health, and on the current staging and the cor-
responding prognosis.
Table 2 Questions of the activity questionnaire
1. I don’t have any trouble putting on my socks/shoes on my own. (absolutely true = 1 to absolutely false = 6)
2. I don’t have any trouble putting on a t-shirt on my own. (absolutely true = 1 to absolutely false = 6)
3. I have trouble getting up from a low chair. (absolutely true = 1 to absolutely false = 6)
4. I don’t have any trouble getting into a car. (absolutely true = 1 to absolutely false = 6)
5. The longest distance I can currently walk is approx. <100 m; 100–500 m; 500-1000 m; 1–2 km; 2–5 km; > 5 km
6. After covering this distance I’m thoroughly exhausted. (absolutely true = 1 to absolutely false = 6)
7. I’m still capable of riding a bicycle yes = 1; no = 0
8. The longest riding distance I’m still capable of is approx. <2 km; 2–5 km; 5–10 km; 10–15 km; 15–20 km; >20 km
9. After riding this distance I’m thoroughly exhausted. (absolutely true = 1 to absolutely false = 6)
10. I can walk up stairs from one storey to the next with ease. (absolutely true = 1 to absolutely false = 6)
11. I don’t have any trouble carrying a shopping basket approx. 50 m. (absolutely true = 1 to absolutely false = 6)
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The total number of patients undergoing radiotherapy in
the radiation oncology department of the Heidelberg
University Clinic for metastatic processes in the verte-
bral column in the recruitment period is approximately
120, about 90 of whom shall fulfill the inclusion criteria.
On account of the explorative character of this study it
was not possible to estimate the total number of cases;
with a scheduled number of 30 patients per group, it
will, however, be possible to detect a standardized mean-
value effect of 0.8 with a power of 80% and an α signifi-
cance level of 5%. All variables were analyzed descriptively
by tabulation of the measures of the empirical distributions.
According to the scale level of the variables, means, stand-
ard deviations, medians as well as minimum and maximum
or absolute and relative frequencies, respectively, will be re-
ported. The results are reported as p-values. For all analysis,
a p-value of 0.05 or less was considered significant. All stat-
istical analyses were done using SAS software Version 9.1
(SAS Institute, Cary, NC, USA).
Results
Groups were balanced at baseline. The median follow-up
was 3.3 months for both groups (range 2.8-4.0 months). Pa-
tients in the intervention group (Arm A) completed the iso-
metric resistance training of the autochthonous muscles in
83.3% (n = 25) of all cases. Five patients (16.7%) died within
the first twelve weeks following RT due to tumor progres-
sion. In Arm B, 7 patients (23.3%) died within 3 months. In
the intervention group, fatigue and psychological stress de-
creased during the training program (p < .001), and there
was a significant difference between baseline and after
3 month in both parameters (p < .001) (Table 3). Patho-
logical fractures or progression of a neurological deficit did
not occur in both groups. Patients in Arm A improved
significantly in the chair-stand test (p < .0001) over the
course, and between groups in favor to intervention group
(p < .001). No significant difference could be measured in
the control group (p = .525) (Table 4). This result is alsoreflected in the evaluation of the activity questionnaire
(Tables 2 and 5). After three months, none of the patients
(n = 0; 0%) in the intervention group required an ortho-
pedic thoracic corset any longer, while the difference in
Arm B was unchanged (n = 4; 17.4%).
The local control of metastases under treatment was
100% in both groups. In Arm A, no progression of other
metastases in the vertebral column was seen after three
months, while progression was recorded in 17.4% of the
patients in Arm B (n = 4).
The intervention group improved in pain score (VAS,
0–10) over the course (p < .001), and was significant better
between groups (p = .003) after 3 month. The results for
complete pain response and partial response were 48%
and 20%, respectively, in Arm A and 21.7% and 26.1% in
Arm B. The overall pain response showed no significant
difference between groups (p = .158) (Table 4).
The median overall survival of the intervention
group was 88.6 months, six-month survival 90%, and
twelve-month survival 83.1%. The median overall sur-
vival of the control group was 72 months, and six- and
twelve-month survival 96.6% and 78.6%, respectively
(p = .626). No statistically significant difference was ob-
served (Figure 3). Median bone survival was 23.3 months
in Arm A (range 2.1-52.0) and 11.2 months in Arm B
(range 1.3-96.4) (p = .558).
Discussion
Bone metastases are a very frequent secondary diagnosis as-
sociated with an advanced tumor disease, with the vertebral
column being the most frequent localization [17,18]. Pa-
tients affected by this condition are usually immobilized,
primarily due to the risk of pathological fractures and the
related danger of spinal cord compression. Previous clinical
studies have shown that tumor patients may profit from
physical training measures during and following medical
treatment [6,7,9,19,20]. Patients in the intervention group
felt less exhausted and less psychically stressed following
the training session; moreover, the pain felt during training
Table 3 Intervention group
Mean SD Min Median Max
Previous training
Felling sluggish (pts. 1–6) 2.8 0.9 1.2 2.9 5.4
Psychological stress (pts. 1–6) 2.6 0.9 1.2 2.8 5.1
After training
Felling sluggish (pts. 1–6) 2.2 0.9 1.1 2.0 5.0
Psychological stress (pts. 1–6) 2.1 0.8 1.1 1.9 4.6
Teatment effect (previous vs. after) p < .001 in both parameters
Difference T0-T2 p < .001 in both parameters
Pain during intervention (n, %) 5 (16.7)
Pain medication needed (n, %) 4 (13.3)
This table shows the results of a questionnaire previous and after intervention respective feeling sluggish and psychological stress (pt 1 = least to pt 6 =most).
Treatment effect (previous vs. after training) and difference in both parameters were significant (p < .001). Pain during intervention was documented according
VAS-scale (0–10). Concomitant pain medication during intervention was evaluated (number of patients, %).
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exercise, however, vary according to the degree of the pri-
mary disease, the medical treatment principles, and the pa-
tient’s current lifestyle [5]. The German Association for
Sports Medicine and Prevention and the German Cancer
Society have published guidelines for the design of training
and sports programs for tumor patients; in these guidelines,
the targeted sports intervention is deemed contraindicated
in patients with bone metastases [21]. The promoting
effects of differentiated training to support the vertebral
column of patients with bone metastases have not yet
been investigated. Current strength-training regimens withTable 4 Results of “chair stand test” and pain response
Chair stand test Intervention group
n Mean SD Min
Baseline (t0) 30 5.1 1.4 2.0
End of RT (t1) 30 6.7 1.9 4.0
After 3 month (t2) 25 9.0 2.6 5.0
Treatment effect within groups (t2) p < .001
Treatment effect between groups (t2) p < .001
pain response (VAS 0–10)
Pain score at baseline (VAS) 30 4.8 2.1 0.5
Pain score end of RT (VAS) 30 2.4 2.0 0.0
Pain score after 3 month (VAS) 25 1.9 1.4 0.0
Treatment effect within groups (t2) p < .001
Treatment effect between groups (t2) p = 0.003
No response (n, %) 8 32%
Partial response (n, %) 5 20%
Complete response (n, %) 12 48%
Treatment effect (t2) p = 0.158
The “chair stand test” showed an improvement in intervention group over the cour
intervention group improved in pain score (VAS, 0–10) over the course (p < .001), a
pain response showed no significant difference between groups (p = .158). Wilcoxo
Chi-square test was measured for pain response.strong anabolic effects on muscles and bones may exert
an influence in countering specific side-effects of tumor
therapy, helping patients to improve their physical func-
tion [8]. A training exertion between 20 and 30% of max-
imum power causes neither an increase nor a decrease in
strength, and can be seen as corresponding with the daily
load of induced muscle tensions [22]. When a patient is
immobilized, the muscles are exerted only to a degree not
exceeding 20%, resulting in their atrophy [22]. The train-
ing threshold, thus, lies at approximately 30-40% of the
maximum muscle strength, above which training can have
a positive effect [22]. This was the level of exercise at(n = 30) Control group (n = 30)
Median Max n Mean SD Min Median Max
5.0 7.0 30 4.6 2.0 0.0 4.0 9.0
6.5 12.0 30 4.9 2.2 0.0 5.0 10.0
10.0 13.0 23 5.0 2.7 0.0 5.0 10.0
p = 0.525
5.0 9.0 30 5.1 2.7 0.0 5.3 9.0
2.0 8.0 30 3.3 2.5 0.0 3.3 9.0





se (p < .001), and between groups in favor to intervention group (p < .001). The
nd was significant better between groups (p = .003) after 3 month. The overall
n U test was used between groups, signed-rank test was used within groups.
Table 5 Results of activity questionnaire of both groups
Intervention group p-value Control group (n = 30) p-value
Baseline (t0) (n = 30) After 3 month (t2) (n = 25) Baseline (t0) (n = 30) After 3 month (t2) (n = 23)
Q Mean Min Max Mean Min Max Mean Min Max Mean Min Max
1 2.5 1.0 6.0 1.8 1.0 5.0 0.063 3.6 1.0 6.0 3.2 1.0 6.0 0.022
2 2.6 1.0 6.0 2.0 1.0 6.0 0.137 3.4 1.0 6.0 3.6 1.0 6.0 0.028
3 3.5 1.0 6.0 3.6 1.0 6.0 0.490 3.8 1.0 6.0 3.1 1.0 6.0 0.255
4 2.3 1.0 6.0 1.9 1.0 6.0 0.011 3.6 1.0 6.0 3.1 1.0 6.0 0.063
5 2326.7 100 5000 2768.0 100 5000 0.061 1430.0 100 5000 1882.6 100 5000 0.109
6 3.0 1.0 6.0 2.8 1.0 6.0 1.000 2.9 1.0 6.0 2.6 1.0 6.0 0.791
7 0.4 0.0 1.0 0.5 0.0 1.0 0.426 0.3 0.0 1.0 0.4 0.0 1.0 0.548
8 2466.7 0.0 10000 4400.0 0.0 15000 0.708 3000.0 0.0 20000 3347.8 0.0 20000 0.478
9 1.3 0.0 6.0 1.6 0.0 6.0 0.848 1.6 0.0 6.0 1.8 0.0 6.0 0.945
10 2.8 1.0 6.0 2.6 1.0 6.0 0.008 4.1 1.0 6.0 3.7 1.0 6.0 0.080
11 3.8 1.0 6.0 3.3 1.0 6.0 0.675 4.0 1.0 6.0 3.3 1.0 6.0 0.974
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weights, although it was not possible to measure the max-
imum strength in these patients. In the intervention
group, this training effect resulted in an increase in mobil-
ity, chair-stand test and activity questionnaire were used.
The quantitative measurement of mobility for these pa-
tients was difficult, due the increased risk of pathological
fracture. Therefore other methodical devices were not ac-
ceptable. We were not able to assess the strengthening of
the muscles quantitatively, but this test was almost related
to mobility for palliative patients. In addition mobility was
evaluated in our non-validated questionnaire. The results
of the activity questionnaire further emphasized the bene-
fits attained in the intervention group as opposed to the
control group. Other existing validated questionnaires had
no information with respect to daily activity in patients
with bone metastases, so we created questions independ-
ently which were relevant for these palliative patients. TheFigure 3 Overall survival of both arms, time in month.questionnaire was not based on an existing one. However,
this represented a major limitation. An adequate training
duration corresponds to 20-30% of the time of muscle ten-
sion until exhaustion, and this was approximately the limit
we used for the exercises [22]. Regarding age and gender,
there are indications of differing degrees to which muscles
can be trained; in our study group, however, due to the
homogeneous distribution this difference appears to be
negligibly small. Lasting only a few seconds, the individual
muscle-tension is kept so short that no load is exerted on
the cardiovascular system, meaning that these exercises
can be carried out also by patients with pre-existing in-
ternal diseases. In their review, Knols et al. [5] demon-
strated that the positive effects of exercise therapy vary
depending on the type and stage of tumor, pharmaceutical
therapy, therapeutical procedures, and patient lifestyle. In
the review of the practicability it was not necessary to
standardize the conditions, which is why simple-to-perform
exercises were selected to form this standardized training
program. On account of the raised risk of fracture, no extra
weights were used and active movements of the vertebral
column were avoided. As a measure to ensure an adequate
training stimulus, which optimally lies at 40-50% of the
maximum isometric strength with extra weights, the indi-
vidual exercises were repeated a number of times, ensuring
appropriate pauses between each set of exercises.
A decisive step was to initially classify the metastases as
“stable” or “unstable”, which was done according to the
Taneichi scores. According to Taneichi et al. [12], significant
risk factors included the destruction of the costovertebral ar-
ticulation, the size of the tumor in the thoracic region (Th1-
Th10), and the destruction of the pedicle as the main factors
in the thoracolumbar and lumbar spine. Not only is the
standardized assessment of the stability in clinical practice
by means of a score rating of relevance when making the
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formation for decisions regarding mobility therapy. The
feasibility of exercise in tumor patients has already been
demonstrated by a number of studies [9,10,19,20,23,24]. In
their study Murnane et al. [25] were able to show that the
majority of patients wish to take physical exercise as an
adjunct to RT. In our investigation, none of the patients
withdrew from training or refused to take part because of
the training program. Hayes et al. [6] describe that phys-
ical exercise is associated with a benefit during and after
tumor treatment, and indeed is even capable of reducing
the impact of the side-effects of therapy and the symptoms
of the underlying disease. The evidence emphasizes the ef-
fect of positive physiological and psychological benefits of
mobility therapy during and after tumor therapy [8].
The local three-month controls were performed in
100% in both groups; the interesting long-term results
have not yet been evaluated, and the results will be pre-
sented in the near future.
The pain-reducing effect in the three-month course of
the study showed a positive course in Arm A, but not sig-
nificantly better. In a prospective collective group of 518
patients, Chow et al. were able to demonstrate complete
and partial response rates at the 3-month follow up of
21% to 25% and 26% to 30% in RT group, respectively
[26]. Our results in the control group were comparable
with these findings: the pain response in the intervention
group was 48% and 20% in the three-month course.
There were no significant differences between the groups
regarding overall survival (OS). Due to the differing tumor
entities and the small number of patients involved, any
comparison with other data cannot be representative. The
bone survival data showed median values of 23.3 vs.
11.2 months; here, too, it was not possible to demonstrate a
significant difference between the two groups.
The weak points of the study were the small number of
subjects, the variety of primary tumors, the exclusion of
the cervical spine, and the non-validated score of the ac-
tivity questionnaire, purpose-made for this trial. The pa-
tients’ compliance with the training program in their
home setting could naturally only be checked by reviewing
the documentation forms completed by the patients them-
selves. The study’s strong points comprised the classifica-
tion of stability and the very first application of a physical
exercise program in patients with metastases in vertebral
bodies as a measure to enhance their mobility.
Conclusions
In this group of patients we were able to show that guided
isometric training of the paravertebral muscles can be
safely practiced in palliative patients with stable bone me-
tastases of the vertebral column, improving their pain
score and mobility. Large controlled trials are necessary to
confirm these findings.Competing interests
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